CIK 0001070081
- Large accelerated filer
PTC THERAPEUTICS, INC.
Sign in to watch- Ticker
- PTCT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043416587
- Phone
- +1 908-222-7000
- Business address
- 500 WARREN CORPORATE CENTER DRIVE, WARREN, NJ, 07059
- Former names
- PTC THERAPEUTICS INC
- 4 Planned sale EXEC. VP AND CLO sold 3,395 shares at an average $28.85 ($97,960)
- 4 Planned sale CHIEF TECHNICAL OPS OFFICER sold 2,910 shares at an average $28.85 ($83,950)
- 4 Planned sale CHIEF EXECUTIVE OFFICER sold 10,107 shares at $27.15 ($274,393)
- 4 Grant or award CHIEF EXECUTIVE OFFICER acquired 75,000 shares (grant or award)
- 4 Open-market buy CHIEF FINANCIAL OFFICER bought 7,700 shares at $25.81 ($198,736)
- 4 Open-market sale Director sold 11,666 shares at an average $39.86 ($464,972)
- 4 Grant or award CHIEF FINANCIAL OFFICER acquired 26,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Director sold 1,000 shares at $44.86 ($44,860)
- 4 Grant or award Director acquired 6,333 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Director sold 9,768 shares at an average $59.53 ($581,515)
- 4 Planned sale CHIEF BUSINESS OFFICER sold 8,416 shares at an average $58.97 ($496,282)
- 4 Planned sale CHIEF BUSINESS OFFICER sold 8,836 shares at an average $58.52 ($517,089)
- 4 Planned sale Director sold 23,000 shares at an average $55.08 ($1,266,930)
- 4 Planned sale SVP, FINANCE & CAO sold 4,692 shares at an average $55.06 ($258,326)
- 4 Planned sale Director sold 4,328 shares at an average $55.05 ($238,258)
- 4 Planned sale CHIEF BUSINESS OFFICER sold 732 shares at $52.04 ($38,096)
- 4 Planned sale CHIEF EXECUTIVE OFFICER sold 1,211 shares at $52.04 ($63,025)
Page 10 of 31 · 618 filings